Tech Company Financing Transactions
Tango Therapeutics Funding Round
Tango Therapeutics, based in Cambridge, secured $60 million from Boxer Capital, Casdin Capital and Cormorant Asset Management.
Transaction Overview
Company Name
Announced On
4/10/2020
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series B
Investors
Proceeds Purpose
This financing will support our lead program into IND-enabling studies early next year as well as multiple other ongoing target and drug discovery efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Binney St. 700
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of targeted therapies to people with cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barbara Weber
Chief Financial Officer
Daniella Beckman
Chief Scientific Officer
Alan Huang
Browse more venture capital transactions:
Prev: 4/10/2020: Airbrake venture capital transaction
Next: 4/10/2020: Seeqc venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs